CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 291 shares (to pay taxes)
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 1,155 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 1,353 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 734 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 2,933 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 791 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 801 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,585 shares (to pay taxes)
Page 22 of 39 · 778 filings